|
| 37399719 | Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease. | Biomed Pharmacother | 2023 |
| 34800542 | PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer. | Exp Cell Res | 2021 |
| 33878292 | Structural basis for the association of PLEKHA7 with membrane-embedded phosphatidylinositol lipids. | Structure | 2021 |
| 32462959 | A Robust and Cost-Effective Luminescent-Based High-Throughput Assay for Fructose-1,6-Bisphosphate Aldolase A. | SLAS Discov | 2020 |
| 31040156 | An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors. | Cancer Res | 2019 |
| 31803426 | Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples. | Chem Sci | 2019 |
| 31615811 | Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors. | Cancer Res | 2019 |
| 31585939 | Absence of HIF1A Leads to Glycogen Accumulation and an Inflammatory Response That Enables Pancreatic Tumor Growth. | Cancer Res | 2019 |
| 28820953 | A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate Aldolase. | SLAS Discov | 2018 |
| 26983373 | Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling. | Antioxid Redox Signal | 2017 |
| 28468778 | Modeling of Patient-Derived Xenografts in Colorectal Cancer. | Mol Cancer Ther | 2017 |
| 25410163 | HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. | Gut | 2016 |
| 27806312 | Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer. | Oncotarget | 2016 |
| 27261507 | Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target. | Cancer Res | 2016 |
| 27167191 | Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. | Oncotarget | 2016 |
| 27187615 | ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. | Nat Commun | 2016 |
| 26799785 | A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice. | Hepatology | 2016 |
| 26955870 | Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems. | BMC Cancer | 2016 |
| 25421578 | Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. | Cancer Res | 2015 |
| 26460303 | Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer. | J Clin Oncol | 2015 |
| 25449779 | A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. | Cancer Lett | 2015 |
| 24177031 | FXR silencing in human colon cancer by DNA methylation and KRAS signaling. | Am J Physiol Gastrointest Liver Physiol | 2014 |
| 25344581 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | Mol Cancer Ther | 2014 |
| 24681952 | PATHOME: an algorithm for accurately detecting differentially expressed subpathways. | Oncogene | 2014 |
| 23251002 | Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. | Clin Cancer Res | 2013 |
| 23859776 | Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [(131)I] analogue as useful PET tracers for PI3-kinase. | Bioorg Med Chem | 2013 |
| 23633488 | Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. | Cancer Res | 2013 |
| 22247021 | Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. | J Natl Cancer Inst | 2012 |
| 22741038 | Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium. | Transl Oncol | 2012 |
| 22912394 | The promise of patient-derived xenografts: the best laid plans of mice and men. | Clin Cancer Res | 2012 |
| 22818162 | Passing the baton: the HIF switch. | Trends Biochem Sci | 2012 |
| 22434430 | AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. | Cancer Res | 2012 |
| 22275514 | Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells. | Mol Cancer Res | 2012 |
| 20473884 | Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma. | Int J Cancer | 2011 |
| 21867428 | Radiation Resistance in Cancer Therapy: meeting summary and research opportunities. Report of an NCI Workshop held September 1-3, 2010. | Radiat Res | 2011 |
| 21512133 | The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. | Cancer Res | 2011 |
| 21740251 | Radiation Resistance in Cancer Therapy: Meeting Summary and Research Opportunities: Report of an NCI Workshop held September 1-3, 2010. | Radiat Res | 2011 |
| 21353784 | Development of sulfonamide AKT PH domain inhibitors. | Bioorg Med Chem | 2011 |
| 21364021 | HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance. | Mol Cancer Res | 2011 |
| 21430111 | Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM. | Neuro Oncol | 2011 |
| 21110830 | Recent development of anticancer therapeutics targeting Akt. | Recent Pat Anticancer Drug Discov | 2011 |
| 21069338 | Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. | Cancer Chemother Pharmacol | 2011 |
| 21158718 | PI-3-Kinase inhibitors in colorectal cancer. | Curr Cancer Drug Targets | 2011 |
| 20047145 | The biological effects of isoform-specific PI3-kinase inhibition. | Curr Opin Drug Discov Devel | 2010 |
| 20545760 | IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes. | Exp Dermatol | 2010 |
| 20512076 | Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. | J Thorac Oncol | 2010 |
| 20587661 | Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. | Mol Cancer Ther | 2010 |
| 20156803 | Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. | Neuro Oncol | 2010 |
| 20176047 | Inhibitors of phosphatidylinositol-3-kinase in cancer therapy. | Mol Aspects Med | 2010 |
| 20197390 | Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor. | Mol Cancer Ther | 2010 |